Lasers in Surgery and Medicine · 2005 · 37 citations · 27 references
MedicineDermatologyOncologyCosmetic DermatologyCutaneous OncologyDermatologic SurgeryBasal Cell CarcinomaLaser SurgeryNeoplastic Skin LesionsPhotodynamic TherapySkin TumorsBasal Cell Carcinoma HistopathologyCancer Photodynamic TherapyClinicopathologic FeaturesDermatologic Photodynamic TherapyLasersNodular Basal Cell CarcinomaPigmented Basal Cell CarcinomaSuperficial Basal Cell Carcinoma
BACKGROUND AND OBJECTIVES: We aimed to treat different pathologic types of basal cell carcinomas (BCCs) using photodynamic therapy (PDT). STUDY DESIGN/MATERIALS AND METHODS: Thirty lesions in six patients underwent PDT. The photosensitizer used was Photoheme, a hematoporphyrin derivative IX. It was injected intravenously at the dose of 2-3.25 mg/kg. After 24 hours, the lesions were illuminated by laser light (lambda = 632 nm, light exposure dose = 100-200 J/cm2). Lesions were evaluated pre and post-operatively and at follow-up sessions (of up to 6 months). RESULTS: After a single session of PDT, the average response rate in different histopathologic kinds of basal cell carcinoma (e.g., ulcerative, superficial, nodular, and pigmented forms) were 100%, 62%, 90%, and 14%, respectively. In patients who responded completely, the cosmetic results were excellent and there were no recurrence at 6th month of follow-up. CONCLUSION: Although PDT seems to be an effective treatment modality for superficial, ulcerative, and nodular BCCs, it is not recommended for pigmented lesions.
27
Photoradiation therapy for the treatment of malignant tumors.
Thomas J. Dougherty, J. Kaufman, Abraham Goldfarb et al. · PubMed · 1978 · 1.5K citations
Medicine, Dermatology, Oncology +13
Guidelines for the management of basal cell carcinoma
Telfer, Colver, Bowers · British Journal of Dermatology · 1999 · 341 citations
Medicine, Dermatology, Oncology +17
Photodynamic Therapy for the Treatment of Basal Cell Carcinoma
B. Dale Wilson · Archives of Dermatology · 1992 · 177 citations
Medicine, Dermatology, Oncology +9